{"retracted":false,"update":{"timestamp":1476662400000,"doi":"10.1080/02652048.2016.1231656","type":"correction"},"doi":"10.1080/02652048.2016.1222006","journal":"Journal of Microencapsulation","publisher":"Informa UK Limited","title":"Correction to: Erukula and Chatterjee, Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part II. Albumin-bound carbamazepine nanoparticles (ABCns)"}
